• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

'Digoxin-like' substance in serum of elderly patients.

作者信息

Wickramasinghe L S, Bansal S K, Dillon R D

出版信息

Age Ageing. 1986 Sep;15(5):271-7. doi: 10.1093/ageing/15.5.271.

DOI:10.1093/ageing/15.5.271
PMID:3776749
Abstract

The Amersham Amerlex Radio-immunoassay was used to detect 'digoxin-like' substance in the sera of 37 elderly subjects, nine with renal impairment, 14 with hepatobiliary disease and 14 over-65-years-old controls with no renal or hepatic impairment. In the patients with hepatobiliary disease, digoxin-like substance was detected in 11 out of 14, the level being closely correlated with serum bilirubin (P less than 5.5 X 10(-10)) and significantly but less closely with serum alkaline phosphatase activity (P less than 10(-3)). While serum digoxin-like substance was detectable in seven out of nine patients with renal impairment, there was no correlation between the degree of renal impairment as reflected by blood urea and serum creatinine and serum digoxin-like activity. We suggest that in elderly subjects with renal impairment or hepatobiliary disease these findings should be borne in mind especially when considering digoxin toxicity.

摘要

相似文献

1
'Digoxin-like' substance in serum of elderly patients.
Age Ageing. 1986 Sep;15(5):271-7. doi: 10.1093/ageing/15.5.271.
2
The effect of renal and hepatic impairment and of spironolactone on digoxin immunoassays.
Eur J Clin Pharmacol. 1988;34(3):233-9. doi: 10.1007/BF00540949.
3
An endogenous digoxin-like substance in patients with renal impairment.肾功能损害患者体内的一种内源性类洋地黄物质。
Ann Intern Med. 1983 Nov;99(5):604-8. doi: 10.7326/0003-4819-99-5-604.
4
False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease.肝病患者中通过三种地高辛测定法测得的血清地高辛浓度假阳性结果
Clin Pharm. 1988 Jun;7(6):444-9.
5
Quantitation of interference in digoxin immunoassay in renal, hepatic, and diabetic disease.
Clin Pharmacol Ther. 1997 Apr;61(4):429-41. doi: 10.1016/S0009-9236(97)90193-4.
6
Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
Clin Pharm. 1986 Oct;5(10):810-6.
7
Digoxin-like immunoreactive substance in renal failure: a reappraisal.
Nephron. 1986;44(2):108-10. doi: 10.1159/000183976.
8
Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.血清肌酐浓度正常的老年患者体内的内源性洋地黄样免疫活性物质
Clin Pharm. 1988 Jun;7(6):449-53.
9
Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.重症监护病房患者血浆中洋地黄样免疫反应性物质:与器官功能障碍的关系
Anaesth Intensive Care. 1990 Feb;18(1):45-52. doi: 10.1177/0310057X9001800108.
10
Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications.
Clin Chem. 1985 Sep;31(9):1525-32.

引用本文的文献

1
Total digoxin-like immunoreactive factor(s) in healthy population, uncomplicated term pregnancies and neonates.
J Endocrinol Invest. 1990 Jan;13(1):9-12. doi: 10.1007/BF03348569.